Karen Fancher, PharmD, BCOP, associate professor of pharmacy practice at Duquesne University and clinical oncology specialist ...

Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 and FLT3 inhibitor, today announced that the Company ...

Six-year data show continuous zanubrutinib keeps CLL controlled longer than bendamustine-rituximab, including high-risk ...

Tanya Siddiqi, MD, shares her personal experience using continuous BTK inhibitor therapy for the treatment of patients with ...

While spending is up and consumer sentiment is down, there is another undercurrent behind the numbers.

PORTSMOUTH, Va. (WAVY) – In a video for the Virginia Chapter of Man Up To Cancer called “Gathering of Wolves”, you hear this: ...

At a tense cabinet meeting where several members lobbied on behalf of the shah, he asked: "What are you guys going to advise ...

Imugene Ltd (ASX:IMU, OTC:IUGNF, FRA:ILA) has highlighted encouraging early clinical data and fresh funding in its March 2026 ...

Brooke Hogan has spoken out about rumors that she has a ‘thing’ with Scott McGillivray, her costar on HGTV’s home renovation ...

Patients with multiple myeloma (MM) have a distinct pattern of second primary malignancy (SPM), with a markedly increased ...

Mary Alice Glen was 37 years old when she was diagnosed with breast cancer in 1996. Years earlier, her mother died from ovarian cancer. One of her sisters had breast cancer. A brother h ...

Reports First-Quarter Diluted EPS of $0.39 on a GAAP Basis, a Decrease of 45.8 Percent; Adjusted Diluted EPS of $2.65, an Increase of 7.7 Percent; These Results Include ...